Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy

The inhibitor of DNA binding (Id) proteins are regulators of cell cycle and cell differentiation. Of all Id family proteins, Id1 is mostly linked to tumorigenesis, cellular senescence as well as cell proliferation and survival. Id1 is a stem cell-like gene more than a classical oncogene. Id1 is overexpressed in numerous types of cancers and exerts its promotion effect to these tumors through different pathways. Briefly, Id1 was found significantly correlated with EMT-related proteins, K-Ras signaling, EGFR signaling, BMP signaling, PI3K/Akt signaling, WNT and SHH signaling, c-Myc signaling, STAT3 signaling, RK1/2 MAPK/Egr1 pathway and TGF-β pathway, etc. Id1 has potent effect on facilitating tumorous angiogenesis and metastasis. Moreover, high expression of Id1 plays a facilitating role in the development of drug resistance, including chemoresistance, radiation resistance and resistance to drugs targeting angiogenesis. However, controversial results were also obtained. Overall, Id1 represent a promising target of anti-tumor therapeutics based on its potent promotion effect to cancer. Numerous drugs were found exerting their anti-tumor function through Id1-related signaling pathways, such as fucoidan, berberine, tetramethylpyrazine, crizotinib, cannabidiol and vinblastine.

• Publication year

  2020

• Venue

  International Journal of Medical Sciences

• Publication date

  2020-04-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.7150/ijms.42805PMID 32410828PMCID 7211148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis.

  2020cited by this paper
• Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells

  2019influential reference
• Synchronous co‑expression of Id‑1 and nuclear NF‑κB p65 promotes cervical cancer progression and malignancy, and is associated with a poor prognosis and chemosensitivity.

  2019cited by this paper
• Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways

  2019cited by this paper
• Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure

  2019cited by this paper
• ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.

  2019cited by this paper
• ID1 mediates escape from TGF-β tumor suppression in pancreatic cancer.

  2019cited by this paper
• ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib

  2018cited by this paper
• Prognostic values of the inhibitor of DNA-binding family members in breast cancer

  2018cited by this paper
• microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.

  2018cited by this paper
• The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.

  2018cited by this paper
• The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.

  2017cited by this paper
• siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells

  2017cited by this paper
• Inhibition of ID1–BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy

  2017cited by this paper
• Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis

  2017cited by this paper
• The Id-protein family in developmental and cancer-associated pathways

  2017cited by this paper
• ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

  2017cited by this paper
• CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition

  2017cited by this paper
• Suppression of ID1 expression in colon cancer cells increases sensitivity to 5-fluorouracil.

  2017cited by this paper
• Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.

  2016cited by this paper
• Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling.

  2016cited by this paper
• Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy

  2016influential reference
• Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells

  2016cited by this paper
• Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.

  2016cited by this paper
• Expressions of Inhibitors of DNA Binding-1 and Matrix Metalloproteinase-9 in Colorectal Adenocarcinoma Tissues and Their Correlations with Microvessel Density.

  2016cited by this paper
• Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.

  2016cited by this paper
• Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells

  2016cited by this paper
• The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells.

  2016cited by this paper
• The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells

  2016cited by this paper
• Id1 Deficiency Protects against Tumor Formation in ApcMin/+ Mice but Not in a Mouse Model of Colitis-Associated Colon Cancer

  2015cited by this paper
• Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.

  2015cited by this paper
• Inhibitor of differentiation 4 (ID4): From development to cancer.

  2015cited by this paper
• Peritoneal VEGF-A expression is regulated by TGF-β1 through an ID1 pathway in women with endometriosis

  2015cited by this paper
• Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia.

  2015cited by this paper
• Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma

  2015cited by this paper
• Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis

  2015cited by this paper
• ANXA 1 Ac 2-26 peptide reduces ID 1 expression in cervical carcinoma cultures

  2015cited by this paper
• ANXA1Ac₂₋₂₆ peptide reduces ID1 expression in cervical carcinoma cultures.

  2015cited by this paper
• Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance

  2015cited by this paper
• Transcriptomic and Functional Pathway Analysis of Human Cervical Carcinoma Cancer Cells Response to Microtubule Inhibitor

  2015cited by this paper
• Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression.

  2015cited by this paper
• PTK7 regulates Id1 expression in CD44-high glioma cells.

  2015cited by this paper
• Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.

  2015cited by this paper
• ERβ1 inhibits the migration and invasion of breast cancer cells through upregulation of E-cadherin in a Id1-dependent manner.

  2015cited by this paper
• Inhibitor of DNA-binding protein 1 knockdown arrests the growth of colorectal cancer cells and suppresses hepatic metastasis in vivo.

  2014cited by this paper
• Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer

  2014cited by this paper
• ID1 Promotes Breast Cancer Metastasis by S100A9 Regulation

  2014cited by this paper
• Nicotine-mediated invasion and migration of non-small cell lung carcinoma cells by modulating STMN3 and GSPT1 genes in an ID1-dependent manner

  2014cited by this paper
• Inhibitors of differentiation-1 promotes nitrosopyrrolidine-induced transformation of HPV 16-immortalized cervical epithelial cell

  2014cited by this paper
• Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology.

  2014cited by this paper
• MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling

  2014cited by this paper
• High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients

  2014cited by this paper
• Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.

  2014cited by this paper
• New insights into the role of ID proteins in breast cancer metastasis: a MET affair

  2014cited by this paper
• LIF negatively regulates tumor suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers

  2014cited by this paper
• The ID proteins: master regulators of cancer stem cells and tumour aggressiveness

  2014cited by this paper
• TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.

  2013cited by this paper
• E47 and Id1 Interplay in Epithelial-Mesenchymal Transition

  2013cited by this paper
• Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

  2013influential reference
• ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways

  2013cited by this paper
• Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin

  2013cited by this paper
• TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.

  2013cited by this paper
• Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells

  2013cited by this paper
• The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.

  2013cited by this paper
• Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells

  2013cited by this paper
• Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B

  2012influential reference
• Effect of Id1 knockdown on formation of osteolytic bone lesions by prostate cancer PC3 cells in vivo

  2012cited by this paper
• ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemia

  2012cited by this paper
• Downregulation of Id1 by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway

  2012cited by this paper
• ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21.

  2012cited by this paper
• Malignant glioma: lessons from genomics, mouse models, and stem cells.

  2012cited by this paper
• To differentiate or not — routes towards metastasis

  2012cited by this paper
• Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion

  2012cited by this paper
• ID1 Facilitates the Growth and Metastasis of Non-Small Cell Lung Cancer in Response to Nicotinic Acetylcholine Receptor and Epidermal Growth Factor Receptor Signaling

  2011cited by this paper
• Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cells.

  2011cited by this paper
• Association of Inhibitor of Differentiation 1 Expression With Human Papillomaviruses Infections in Cervical Carcinoma

  2011cited by this paper
• Cyclin D1, Id1 and EMT in breast cancer

  2011cited by this paper
• USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma.

  2011cited by this paper
• TITLE PAGE Title: Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

  2011cited by this paper
• The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation

  2011cited by this paper
• Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro

  2011cited by this paper
• Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway.

  2011cited by this paper
• ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.

  2010cited by this paper
• Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells

  2010cited by this paper
• Correlation between the presence of high-risk human papillomaviruses and Id gene expression in Syrian women with cervical cancer.

  2010cited by this paper
• Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells.

  2010cited by this paper
• Inhibitor of differentiation 1 (Id1) promotes cell survival and proliferation of prostate epithelial cells

  2010cited by this paper
• TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma.

  2010cited by this paper
• Overexpressed Id-1 is associated with patient prognosis and HBx expression in hepatitis B virus-related hepatocellular carcinoma

  2010cited by this paper
• Probasin Promoter—driven Expression of ID1 Is not Sufficient for Carcinogenesis in Rodent Prostate

  2009cited by this paper
• High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia.

  2009cited by this paper
• Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells.

  2009cited by this paper
• KLF17 is a negative regulator of epithelial–mesenchymal transition and metastasis in breast cancer

  2009influential reference
• Mammalian nicotinic acetylcholine receptors: from structure to function.

  2009cited by this paper
• Induction of ID1 expression and apoptosis by the histone deacetylase inhibitor (trichostatin A) in human acute myeloid leukaemic cells

  2008cited by this paper
• Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells.

  2008cited by this paper
• Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo

  2008cited by this paper
• Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response

  2008influential reference
• ID genes mediate tumor reinitiation during breast cancer lung metastasis

  2007cited by this paper
• Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.

  2005cited by this paper

• Integrative Multi-Omics and Machine Learning Identify ID1 as a Candidate Gene Associated with Abdominal Aortic Aneurysm.

  2026cites this paper
• The METTL3-IGF2BP3 axis drives osteosarcoma progression by enhancing ID1 mRNA stability

  2026cites this paper
• ID1 promotes the progression of esophageal cancer via modulating PTEN/YAP/galectin-3 signaling pathway induced proliferation and immune suppression

  2025cites this paper
• Uncovering the Tumorigenic Blueprint of PFOS and PFOA Through Multi-Organ Transcriptomic Analysis of Biomarkers, Mechanisms, and Therapeutic Targets

  2025cites this paper
• A simple liquid 3D cell culture paradigm models oxidative mitochondrial metabolism of epithelial breast cancer cells with relevance for lung metastases

  2025cites this paper
• The chloroform fraction of Dracontium spruceanum modulates gene expression in gastric cancer stem cells

  2025cites this paper
• Hypoxia promotes pancreatic adenocarcinoma progression by stabilizing ID1 via TRIM21 suppression

  2025cites this paper
• CDK inhibitors promote neuroblastoma cell differentiation and increase sensitivity to retinoic acid—a promising combination strategy for therapeutic intervention

  2025cites this paper
• Mitochondrial metabolism: Critical mechanisms underpinning normal hematopoietic stem cell and acute myeloid leukemia stem cell function.

  2025cites this paper
• TRIM21‐Mediated K11‐Linked Ubiquitination of ID1 Suppresses Tumorigenesis and Promotes Cuproptosis in Esophageal Squamous Cell Carcinoma

  2025cites this paper
• Unveiling the Antioxidant Role of Hemp Oils in Cancer Prevention and Treatment

  2025cites this paper
• Recent Advances in the Delivery of Bone Morphogenetic Proteins for Targeting Glioma: An Updated Review

  2025cites this paper
• The important role of myeloid-derived suppressor cells: From hepatitis to liver cancer.

  2025cites this paper
• The Critical Role of Inhibitor of Differentiation 4 in Breast Cancer: From Mammary Gland Development to Tumor Progression

  2025cites this paper
• Exploring ID4 as a driver of aggression and a therapeutic target in triple-negative breast cancer

  2025cites this paper
• Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

  2025cites this paper
• Integrated transcriptomics, proteomics, and pathway enrichment analysis in the spleen and skin of chickens reveal tissue-specific roles for the Marek’s disease virus conserved herpesvirus protein kinase

  2025cites this paper
• Engineering an Organic Nanoplatform for Augmented Pyroeletroimmunotherapy

  2024cites this paper
• Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1.

  2024cites this paper
• Single-cell epigenetic and clonal analysis decodes disease progression in pediatric acute myeloid leukemia

  2024cites this paper
• Cannabidiol effects in stem cells: A systematic review

  2024cites this paper
• Gremlin-2 is a novel tumor suppressor that negatively regulates ID1 in breast cancer

  2024cites this paper
• Progress and perspectives on BMP9-ID1 activation of HIF-1α and VEGFA to promote angiogenesis in hepatic alveolar echinococcosis

  2024cites this paper
• Estrogen receptor alpha (ERα) regulates PARN-mediated nuclear deadenylation and gene expression in breast cancer cells

  2024cites this paper
• Identification and Evaluation of Survival-associated Common Chemoresistant Genes in Cancer

  2024cites this paper
• Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells

  2024cites this paper
• KIS, a target of SOX4, regulates the ID1-mediated enhancement of β-catenin to facilitate lung adenocarcinoma cell proliferation and metastasis

  2024influential citation
• Assessment of ID family proteins expression in colorectal cancer of Iraqi patients

  2024cites this paper
• Prognostic impact of inhibitors of DNA binding proteins1 and inhibitors of DNA binding proteins4 genes expression on adult Egyptian patients with acute myeloid leukemia

  2024cites this paper
• The miR-221/222 regulates the ID1 gene expression through PTEN, c-JUN and ARF4 mediators to control cell proliferation

  2024cites this paper
• A bioinformatics-based approach and expression assay for identification of dysregulated genes in pituitary adenoma.

  2023cites this paper
• RETRACTED ARTICLE: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma

  2023cites this paper
• Breast cancer association with oncogenic papillomaviruses: arguments pro and con

  2023cites this paper
• Cancer invasion and metastasis: Insights from murine pubertal mammary gland morphogenesis.

  2023cites this paper
• Barriers to overcoming immunotherapy resistance in glioblastoma

  2023cites this paper
• Prognostic implications of the ID1 expression in acute myeloid leukemia patients treated in a resource-constrained setting

  2023cites this paper
• Nicotinamide adenine dinucleotide kinase promotes lymph node metastasis of NSCLC via activating ID1 expression through BMP pathway

  2023cites this paper
• Cross-Species Transcriptomics Analysis Highlights Conserved Molecular Responses to Per- and Polyfluoroalkyl Substances

  2023cites this paper
• The Spicy Science of Dendrimers in the Realm of Cancer Nanomedicine: A Report from the COST Action CA17140 Nano2Clinic

  2023cites this paper
• Integrated analysis of proteomics, epigenomics and metabolomics data revealed divergent pathway activation patterns in the recent versus chronic post-traumatic stress disorder.

  2023cites this paper
• Transcription factor 3 promotes migration and invasion potential and maintains cancer stemness by activating ID1 expression in esophageal squamous cell carcinoma

  2023cites this paper
• Journal Pre-proofs Integrated analysis of proteomics, epigenomics and metabolomics data re‐ vealed divergent pathway activation patterns in the recent versus chronic post-traumatic stress disorder

  2023cites this paper
• Identification of ID1 and miR-150 interaction and effects on proliferation and apoptosis in ovine granulosa cells.

  2023cites this paper
• Orai3 Calcium Channel Contributes to Oral/Oropharyngeal Cancer Stemness through the Elevation of ID1 Expression

  2023cites this paper
• Investigation of the ubiquitin proteasome system in pulmonary arterial hypertension

  2023cites this paper
• TBX3 promotes the epithelial mesenchymal transition of cervical cancer by upregulating ID1.

  2023cites this paper
• A novel necroptosis signature for predicting survival in lung adenocarcinoma

  2023cites this paper
• Cytotoxicity of dioncophylline A and related naphthylisoquinolines in leukemia cells, mediated by NF-κB inhibition, angiogenesis suppression, G2/M cell cycle arrest, and autophagy induction.

  2023cites this paper
• Hepatocyte-Specific Smad4 Deficiency Alleviates Liver Fibrosis via the p38/p65 Pathway

  2022cites this paper
• Characterization of the Molecular Alterations Induced by the Prolonged Exposure of Normal Colon Mucosa and Colon Cancer Cells to Low-Dose Bisphenol A

  2022cites this paper
• Hepatocyte-speci�c Smad4 de�ciency alleviates liver �brosis via the p38 / p65 pathway

  2022cites this paper
• Drug Resistance in Cancers: A Free Pass for Bullying

  2022cites this paper
• Identification of immune-associated prognostic biomarkers in lung adenocarcinoma on the basis of gene co-expression network

  2022cites this paper
• Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment

  2022cites this paper
• Construction and experimental validation of a B cell senescence–related gene signature to evaluate prognosis and immunotherapeutic sensitivity in bladder cancer

  2022cites this paper
• Cellular Id1 inhibits hepatitis B virus transcription by interacting with the novel covalently closed circular DNA-binding protein E2F4

  2022cites this paper
• Identification of Differentially Expressed Genes and Pathways in Human Atrial Fibrillation by Bioinformatics Analysis

  2022cites this paper
• The Role and Research Progress of Inhibitor of Differentiation 1 in Atherosclerosis

  2022cites this paper
• Review of potential medical treatments for middle ear cholesteatoma

  2022cites this paper
• Necroptosis-Related Prognostic Signature and Nomogram Model for Predicting the Overall Survival of Patients with Lung Cancer

  2022cites this paper
• RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis.

  2022cites this paper
• ID1 marks the tumorigenesis of pancreatic ductal adenocarcinoma in mouse and human

  2022cites this paper
• Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy

  2022influential citation
• 5-Demethylnobiletin Inhibits Cell Proliferation, Downregulates ID1 Expression, Modulates the NF-κB/TNF-α Pathway and Exerts Antileukemic Effects in AML Cells

  2022cites this paper
• Tongue squamous cell carcinoma resists hyperthermia treatment by promoting Id-1 expression mediated EMT.

  2022cites this paper
• Deubiquitinase USP8 increases ID1 stability and promotes esophageal squamous cell carcinoma tumorigenesis.

  2022cites this paper
• Inhibitor of DNA Binding 2 (ID2) Regulates the Expression of Developmental Genes and Tumorigenesis in Ewing Sarcoma

  2022cites this paper
• Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation

  2022cites this paper
• Chromatin accessibility and transcriptome integrative analysis revealed AP-1-mediated genes potentially modulate histopathology features in psoriasis

  2022cites this paper
• Single-Cell Transcriptome Comparison of Bladder Cancer Reveals Its Ecosystem

  2022cites this paper
• Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines

  2022cites this paper
• Tetramethylpyrazine: A review of the most recent research

  2022cites this paper
• The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target

  2021cites this paper
• Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel

  2021cites this paper
• Multivariate transcriptome analysis identifies networks and key drivers of chronic lymphocytic leukemia relapse risk and patient survival

  2021cites this paper
• Overexpression of Endogenous Retroviruses and Malignancy Markers in Neuroblastoma Cell Lines by Medium-Induced Microenvironmental Changes

  2021cites this paper
• C1QTNF6 promotes Oral squamous cell carcinoma tumorigenesis though enhancing proliferation and inhibiting apoptosis of OSCC cells

  2021cites this paper
• Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1‐mediated EMT

  2021cites this paper
• Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells

  2021cites this paper
• Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis

  2021cites this paper
• Alterations in TGFβ signaling during prostate cancer progression.

  2021cites this paper
• Oncogenic activity and cellular functionality of melanoma associated antigen A3.

  2021cites this paper
• C1QTNF6 promotes oral squamous cell carcinoma by enhancing proliferation and inhibiting apoptosis

  2021cites this paper
• Airway Basal Cells Mediate Hypoxia-Induced EMT by Increasing Ribosome Biogenesis

  2021cites this paper
• Reconstituted HDL-apoE3 promotes endothelial cell migration through ID1 and its downstream kinases ERK1/2, AKT and p38 MAPK.

  2021cites this paper
• Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells

  2019cites this paper
• ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.

  2019cites this paper
• Ten Putative Dysregulated Genes and Potential Mechanism Pathways in Breast Cancer Cell Line Treated with Epigallogatechin Gallate from Prismatomeris

  year unknowncites this paper